Skip to main navigation Skip to search Skip to main content

Daily administration of GIP receptor antagonist alleviates glucose intolerance and counters insulin resistance in an animal model of obesity and type 2 diabetes

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)282-282
JournalDiabetologia
Volume47 (S1
Publication statusPublished (in print/issue) - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this